Investigating the PD-L1:NLRP3 signaling axis as a tumor intrinsic mechanism of adaptive resistance to anti-PD-1 antibody immunotherapy

Univ Of North Carolina Chapel Hill, Chapel Hill NC

Investigators

Linked publications & trials